Institutional investors purchased a net $195.7 thousand shares of SLXP during the quarter ended September 2013 and now own 96.93% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
TIAA-CREF INVESTMENT MANAGEMENT ... Bought 1.3 Million shares of Salix Pharmaceuticals Ltd
SSGA FUNDS MANAGEMENT, INC. Bought 703.0 Thousand shares of Salix Pharmaceuticals Ltd